Copeptin testing in acute myocardial infarction: ready for routine use? - Wikidata - awgldk - TriplyDB

Copeptin testing in acute myocardial infarction: ready for routine use?

Copeptin testing in acute myocardial infarction: ready for routine use?

http://www.wikidata.org/entity/Q35556651

about

Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: study protocol for an international, prospective, multicentre cohort trial.Novel biomarkers predicting cardiac function after acute myocardial infarction.The role of circulating microRNAs in acute coronary syndromes: ready for prime time?Circulating micro ribonucleic acids in cardiovascular disease: a look beyond myocardial injury.Diagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis

P2860

Q37356064-92BE186B-623F-4F5A-A842-988927A3B699 Q38841682-E79BF747-D3E8-468A-A27D-57E9E7BC9494 Q42330837-0378B44C-BBD8-4CAC-8675-E7CCBE1AD1F8 Q42370383-AC3C8003-6632-4C4C-88D9-9B433DBEA8F2 Q57101391-5D383675-C57B-4F7B-8F1F-FBC2BD86B5C2

P2860

Copeptin testing in acute myocardial infarction: ready for routine use?

http://www.wikidata.org/entity/Q35556651

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Copeptin testing in acute myocardial infarction: ready for routine use?

@ast

Copeptin testing in acute myocardial infarction: ready for routine use?

@en

type

label

Copeptin testing in acute myocardial infarction: ready for routine use?

@ast

Copeptin testing in acute myocardial infarction: ready for routine use?

@en

prefLabel

Copeptin testing in acute myocardial infarction: ready for routine use?

@ast

Copeptin testing in acute myocardial infarction: ready for routine use?

@en

P1433

Q35556651-B79089A9-48BA-4417-BEE9-17AC2A9C4B3A

P1476

Q35556651-199C4DC4-6AE7-46CE-AEBE-26ABD499668C

P2093

Q35556651-18796277-722A-41DF-8130-69D58C3A3F9A

Q35556651-A3FC86C0-CC83-47C7-BCC9-6A7836449A4A

Q35556651-BE3C2B13-CE09-4EAC-AB37-A158F0BC4A9E

Q35556651-EDB88767-A881-48F6-A696-E93AC53E9138

P275

Q35556651-62D97700-2E89-4EFE-BA9C-7CF38658D99B

P2860

Q35556651-00F606AA-1B92-4EA1-A281-3F054CC90C3D

Q35556651-0A256726-2E8E-4A1E-8CDF-0B4940BD11BC

Q35556651-0DF485EE-1950-425A-BC53-E76B0CDE171F

Q35556651-0FB00E42-940C-40F9-94DB-D8D56C6A9EEB

Q35556651-103188A1-A7E8-4112-B6C3-F90B4C90A25C

Q35556651-158730E4-5020-43E3-88E9-C9AD506A14B1

Q35556651-173F4ECB-4A0C-43F6-BF29-BB1209C5C79A

Q35556651-17AE8CDA-2931-48CF-9250-15AFC3955253

Q35556651-1F756D86-CFF7-482E-9444-17CFF75A512D

Q35556651-221925E4-F8E7-4A56-BBA0-49BA66CDC9CC

P304

Q35556651-A91396EF-B258-4CBA-BCE3-85F01D0847F1

P31

Q35556651-F4F41FD4-CD54-40A6-9A5D-C6BCFB34940A

P356

Q35556651-A36EB342-09C4-43C8-9A60-03AC4E59901B

P478

Q35556651-2E8FF892-3E8F-4EE6-A4B1-93D4CC015B22

P50

Q35556651-89F4ED49-AB18-475A-B6E4-F2823C9EE19F

P5008

Q35556651-D5A64276-6138-46B2-B5E9-C6A0749CE75A

P577

Q35556651-FB62119D-3063-4A6F-9D62-79469D9C636E

P5875

Q35556651-2E3D1DA3-C1EB-465A-B28C-71B8A3C7A697

P698

Q35556651-B79B8530-017C-465A-B7BC-060A716E1365

P921

Q35556651-441464FF-2708-4BB7-BD3D-ABE142837161

Q35556651-79135032-DE9B-4ECC-9DAC-6E67DA5BCE11

Q35556651-93E34818-61DF-4ABB-9BCF-C124D1AADF66

P932

Q35556651-6D263093-04FF-494E-8F17-0E7374C7EEE1

P356

P1433

Disease Markers

P1476

Copeptin testing in acute myocardial infarction: ready for routine use?

@en

P2093

Bernhard Metzler

http://www.w3.org/2001/XMLSchema#string

Gert Klug

http://www.w3.org/2001/XMLSchema#string

Johannes Mair

http://www.w3.org/2001/XMLSchema#string

Sebastian Johannes Reinstadler

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction

Synthesis, transport, and release of posterior pituitary hormones

Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction

Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction.

Effects of aging on vasopressin production in a kindred with autosomal dominant neurohypophyseal diabetes insipidus due to the DeltaE47 neurophysin mutation.

Plasma and platelet vasopressin in essential hypertension and congestive heart failure.

A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study.

Circulating levels of copeptin, a novel biomarker in pre-eclampsia.

C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.

P304

614145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/614145

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Josef Feistritzer

P5008

P577

2015-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275724092

http://www.w3.org/2001/XMLSchema#string

P698

25960596

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

P932

4415476

http://www.w3.org/2001/XMLSchema#string